Potential COVID-19 Vaccine Still Not in Canada, Three Months After Approval for Trials

Matthew Herder, Redmond Shannon

    Research output: Other contribution

    Abstract

    Shipments of a Chinese and Canadian-developed COVID-19 candidate vaccine remain delayed from getting to Canada, more than three months after Health Canada approved them for Phase 1 trials here.

    Original languageCanadian English
    Publication statusPublished - Jan. 1 2020

    Keywords

    • COVID-19
    • Vaccination Production
    • Canada

    Disciplines

    • Food and Drug Law
    • Health Law and Policy
    • Law
    • Law and Society
    • Science and Technology Law

    Fingerprint

    Dive into the research topics of 'Potential COVID-19 Vaccine Still Not in Canada, Three Months After Approval for Trials'. Together they form a unique fingerprint.

    Cite this